OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 3123 citations as per Google Scholar report
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Year wise published articles |
36 | 33 | 60 | 30 | 45 | 44 | 107 | 89 |
Year wise citations received |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 3123 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2018 | 22 |
Rowe M (2016) Will General Practitioners be adequately prepared to meet the complexities of enhanced dementia screening for people with learning disabilities and Down syndrome: key considerations. British Journal of Learning Disabilities 44: 43-48. |
|
View at Publisher | View at Google Scholar | |
Singh BM, Mohanvir K, Nishit G, Kumar BV. RESEARCH AND REVIEWS: JOURNAL OF MEDICAL AND HEALTH SCIENCES. |
|
View at Publisher | View at Google Scholar | |
Sabbagh M, Edgin J (2016) Clinical assessment of cognitive decline in adults with Down syndrome. Current Alzheimer Research 13: 30-34. |
|
View at Publisher | View at Google Scholar | |
Florencia Iulita M, Caraci F, Claudio Cuello A (2016) A link between nerve growth factor metabolic deregulation and amyloid-β-driven inflammation in down syndrome. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 15: 434-447. |
|
View at Publisher | View at Google Scholar | |
Gruszecka A, KopczyÅski P, CudziÅo D, LipiÅska N, Romaniuk A, et al. (2015) Telomere Shortening in Down Syndrome Patients—When Does It Start?. DNA and cell biology 34: 412-417. |
|
View at Publisher | View at Google Scholar | |
Miller N (2016) Aluminum in childhood vaccines is Unsafe. Journal of American Physicians and Surgeons 21. |
|
View at Publisher | View at Google Scholar | |
Hill JM, Dua P, Clement C, Lukiw WJ (2014) An evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in Alzheimer's disease (AD). Frontiers in neuroscience 8: 347. |
|
View at Publisher | View at Google Scholar | |
Pogue AI, Jones BM, Bhattacharjee S, Percy ME, Zhao Y, et al. (2012) Metal-sulfate induced generation of ROS in human brain cells: detection using an isomeric mixture of 5-and 6-carboxy-2′, 7′-dichlorofluorescein diacetate (carboxy-DCFDA) as a cell permeant tracer. International journal of molecular sciences 13: 9615-9626. |
|
View at Publisher | View at Google Scholar | |
Shaw CA, Seneff S, Kette SD, Tomljenovic L, Oller JW, et al. (2014) Aluminum-induced entropy in biological systems: implications for neurological disease. Journal of toxicology 2014. |
|
View at Publisher | View at Google Scholar | |
Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI (2013) Studying micro RNA function and dysfunction in Alzheimer’s disease. Frontiers in genetics 3: 327. |
|
View at Publisher | View at Google Scholar | |
Das D, Medina B, Baktir MA, Mojabi FS, Fahimi A, Ponnusamy R, Salehi A. Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome. Neuroscience letters. 2015 Sep 14;604:91-6. |
|
View at Publisher | View at Google Scholar | |
Hill EA. Obstructive sleep apnoea/hypopnoea syndrome in adults with Down syndrome. Breathe. 2016 Dec 1;12(4):e91-6. |
|
View at Publisher | View at Google Scholar | |
Hill CM, Evans HJ, Elphick H, Farquhar M, Pickering RM, Kingshott R, Martin J, Reynolds J, Joyce A, Rush C, Gavlak JC. Prevalence and predictors of obstructive sleep apnoea in young children with Down syndrome. Sleep Medicine. 2016 Dec 31;27:99-106. |
|
View at Publisher | View at Google Scholar | |
Sharma R, Harish R. Research & Reviews: Journal of Medical and Health Sciences. month.;4:3. |
|
View at Publisher | View at Google Scholar | |
Fernandez F, Nyhuis CC, Anand P, Demara BI, Ruby NF, Spanò G, Clark C, Edgin JO. Young children with Down syndrome show normal development of circadian rhythms, but poor sleep efficiency: a cross-sectional study across the first 60 months of life. Sleep Medicine. 2017 May 31;33:134-44. |
|
View at Publisher | View at Google Scholar | |
Hindley TR. Sleep and Language in Typical and Atypical Development. |
|
View at Publisher | View at Google Scholar | |
ALa N, JCNa A, DSb N, TILa A, ETa K. Research & Reviews: Journal of Medical and Health Sciences. |
|
View at Publisher | View at Google Scholar | |
Pravallika S. Research & Reviews: Journal of Medical and Health Sciences. |
|
View at Publisher | View at Google Scholar | |
Singh BM, Mohanvir K, Nishit G, Kumar BV. RESEARCH AND REVIEWS: JOURNAL OF MEDICAL AND HEALTH SCIENCES. |
|
View at Publisher | View at Google Scholar | |
Sharma VK, Sharma P, Deshmukh R, Singh R. Age Associated Sleep Loss: A Trigger For Alzheimer's Disease. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2015 Mar 1;25(1):78-88. |
|
View at Publisher | View at Google Scholar | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals